DRIO - DarioHealth Corp.

9.7
-0.290   -2.990%

Share volume: 17,131
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$9.99
-0.29
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
35%
Profitability 25%
Dept financing 17%
Liquidity 51%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-9.77%
1 Month
-5.92%
3 Months
-20.16%
6 Months
5.43%
1 Year
1,230.59%
2 Year
463.95%
Key data
Stock price
$9.70
P/E Ratio 
0.00
DAY RANGE
$9.31 - $9.79
EPS 
$3.36
52 WEEK RANGE
$0.38 - $17.74
52 WEEK CHANGE
$1,345.60
MARKET CAP 
39.469 M
YIELD 
N/A
SHARES OUTSTANDING 
6.768 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
1.49
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,548
AVERAGE 30 VOLUME 
$19,400
Company detail
CEO: Erez Raphael
Region: US
Website: mydario.com
Employees: 200
IPO year: 2013
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs.

Recent news